918-P: Real-World Association of Glucose Monitoring Frequency and Glycemic Metrics in the United States

• DOI: 10.2337/db19-918-p
• Publication Date: 2019-06-05T03:39:44Z
• Authors: EUGENE WRIGHT; NAUNIHAL VIRDI; TIMOTHY DUNN
• Keywords: Decile

Global data from real world use of flash glucose monitoring have correlated higher frequency scanning with better glycemic control. Because became available in late 2017 the United States, U.S. was not captured early global analysis. The objective this study highlight outcomes patients using A server collected deidentified who uploaded their system readers. Data within were analyzed through September 2018. Individuals divided into 10 equal sized groups based on frequency. Average time range (70- 180 mg/dL) and above mg/dL calculated for each group. This analysis includes 21,853 readers, 115,221 sensors, 102 million values an average 9 scans per day. Patients lowest decile (3.4 day) had 55% 41% above. highest (30.7 74% 21% represents a 49% reduction target 34% increase range. Real shows how correlates hyperglycemia. is consistent prior analyses concluding that diabetes monitor more frequently derive greater benefit than less frequently. Disclosure E. Wright: Advisory Panel; Self; Abbott, Sanofi US, Voluntis USA. Consultant; Boehringer Ingelheim Pharmaceuticals, Inc. Speaker's Bureau; Eli Lilly Company. Other Relationship; American Diabetes Association, Medscape, UpToDate. N. Virdi: Employee; Proteus Digital Health. Stock/Shareholder; Johnson & Johnson. T. Dunn: Abbott Laboratories.